Glaucoma secondary to intraocular tumors

Camp, David; Yadav, Prashant; Dalvin, Lauren A; Shields, Carol L.

doi:10.1097/icu.0000000000000550

Cited by 51 publications

(26 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Choroidal melanoma management includes radiotherapy, local resection or enucleation especially for unresolving cases. 3 Survival depends upon early diagnosis and younger age of the patient, both of which were not so in this case. Unfortunately our patient had liver metastasis at presentation, which is the most common site of metastasis of choroidal melanoma.…”

Section: Discussionmentioning

confidence: 74%

“…6 Tumors of the posterior segment are more likely to cause glaucoma. 3,6 The secondary glaucoma has been reported to be due to various mechanisms like angle invasion of tumor cells, angle closure by mass effect on the iris, iris neovascularization, hyphema and supra choroidal hemorrhage. 3,7,8 Fig.…”

Section: Discussionmentioning

confidence: 99%

“…3,6 The secondary glaucoma has been reported to be due to various mechanisms like angle invasion of tumor cells, angle closure by mass effect on the iris, iris neovascularization, hyphema and supra choroidal hemorrhage. 3,7,8 Fig. 4: Enucleated right eye showing extra scleral extension in thesuperotemporal quadrant.…”

Section: Discussionmentioning

confidence: 99%

“…1,2 Uveal melanoma has an incidence of 5.1 cases per million, with choroidal melanoma representing 90% of all cases. 3 Choroidal melanomas are usually found incidentally on slit-lamp examination and fundoscopy. A quarter of them are asymptomatic and others may present with symptoms of flashes, floaters or diminution of vision.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Could acute angle closure glaucoma be an indicator of something more ominous?

Kuzhuppilly¹,

Yashaswinee²,

Shenoy³

et al. 2020

IJOOO

View full text Add to dashboard Cite

Choroidal melanoma is the most common intraocular tumor in adults, but is rare in Asia. Patients can present with diminished vision, floaters or visual field loss but most often, tumors are detected incidentally on routine examination. We report a case of a 71 year old female who presented to us with decreased vision and pain in the right eye, who was diagnosed with acute angle closure glaucoma and was treated for the same. On further evaluation, she was found to have choroidal melanoma. This highlights the need for complete evaluation of a successfully treated acute angle closure crisis case.

show abstract

Section: Discussionmentioning

confidence: 74%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Could acute angle closure glaucoma be an indicator of something more ominous?

Kuzhuppilly¹,

Yashaswinee²,

Shenoy³

et al. 2020

IJOOO

View full text Add to dashboard Cite

show abstract

“…Long term follow-up screening for late complications after stereotactic irradiation like SG is necessary. In patients after irradiation techniques in treatment of secondary glaucoma medical therapy, transscleral cyclophtotocagulation, laser iridotomy or minimally invasive glaucoma surgery can be applied for eyes with regressed posterior segment melanoma in patients with no iridociliary involvement, but in some conditions also enucleation is necessary (43). In study of Fatehi (44) they reported patients safety and IOP control after placement of a glaucoma drainage device in eyes treated for uveal melanoma.…”

Section: Discussionmentioning

confidence: 99%

Secondary glaucoma in small versus large uveal melanoma patients treated with stereotactic radiosurgery on linear accelerator

Sekac¹,

S²,

Kollarova³

et al. 2019

BLL

View full text Add to dashboard Cite

AIM: Secondary radiation-related side effects like secondary glaucoma (SG) of different modalities of treatment in uveal melanoma patients can appear in certain interval after therapy. This study describes the incidence of SG in patients after stereotactic radiosurgery (SRS). METHOD: The data of 230 patients treated by SRS were reviewed for SG. Group of 83 patients who were observed 5 years after treatment in one center with follow-up regularly at least 4 times per year were analyzed. RESULTS: In group of 83 patients with the median age 59 years, the median tumor volume at baseline was 0.41 cm 3. The survival without SG after single dose SRS was 94 % in 1.5 year, 77 % in 2 years, 57 % in 3 years, 43 % in 3.5 years, and 18 % in 4.5 year after irradiation. In 6 patients (7.2 %) secondary enucleation was necessary due to SG. Both predictors (tumor volume and age of patient) at the time of SRS were not statistically signifi cant by Cox proportional-hazards regression. CONCLUSIONS: Complications like SG in 5 year interval after irradiation can lead to secondary enucleation of the eye globe (Fig. 3, Ref.

show abstract